TRIM7 suppresses cell invasion and migration through inhibiting HIF‐1α accumulation in clear cell renal cell carcinoma. (30th December 2021)

• Record Type: Journal Article
• Authors: Yuan, Chao; Liu, Junli; Liu, Ling; Jia, Hongying; Gao, Qi; Wang, Xiaoyan; Zhao, Jingjie
• Is Part Of: Cell biology international. Volume 46:Number 4(2022)
• Page Start: 554
• Page End: 567
• Publication Date: 2021-12-30
• Subjects: clear cell renal cell carcinoma -- HIF‐1 -- Src -- TRIM7 -- tumor suppressor -- VEGF; Cytology -- Periodicals; Cells -- Periodicals; 571.605
• DOI: 10.1002/cbin.11750
• Languages: English
• ISSNs: 1065-6995

Abstract

Abstract: Clear cell renal cell carcinoma (ccRCC) is one frequent form of urologic malignancy characterized by deregulated hypoxia‐inducible factor signaling, genetic and epigenetic alterations. Metastasis is the leading cause of mortality from ccRCC, and understanding the underlying mechanism of this event will provide better strategies for its management. Here, we identify tripartite motif containing 7 (TRIM7) as a tumor suppressor in ccRCC cells, which negatively regulates hypoxia‐inducible factor 1α (HIF‐1α) signaling through targeting the proto‑oncogene Src. We observed the downregulated expression of TRIM7 in clinical ccRCC tissues and its correlation with the poor prognosis. In Caki‐1 cells, depletion of TRIM7 increased cell migration and invasion under normoxic and hypoxic conditions. TRIM7 markedly reduced the abundance of Src protein via the ubiquitin‐proteasome pathway. Further study showed that TRIM7 affected HIF‐1α accumulation through targeting either the Src‐triggered PI3K/AKT/mTOR signaling pathway or reactive oxygen species production. Overall, our findings highlight a novel mechanism for negative regulation of HIF‐1 signaling pathway by TRIM7 and define a promising therapeutic strategy for ccRCC by modulating TRIM7.